Amgen Inc (FRA:AMG)
€ 304.75 5.05 (1.69%) Market Cap: 161.98 Bil Enterprise Value: 209.58 Bil PE Ratio: 41.65 PB Ratio: 23.23 GF Score: 91/100

Amgen Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2022 / 01:30PM GMT
Release Date Price: €229.3 (-0.28%)
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

All right. Good morning, everyone. Welcome to another great session here at the Jefferies 2022 in-person Global Healthcare Conference. It's great to see so many faces and friends.

Up here on the stage with us we have Arvind Sood, Vice President of Investor Relations, who everybody knows; as well as Murdo Gordon, EVP of Global Commercial Operations. He's running everything behind the scenes in terms of commercial operations and sales. We obviously have a lot to talk about. We'll go right into it.

Questions & Answers

Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

First, I guess, just maybe big picture for Arvind and Murdo about 2022. We're sort of coming out of COVID. You have guidance. I guess as an analyst, I was sort of surprised we didn't raise guidance. But without getting the nuances of 2022, maybe just talk about your outlook for 2022, and how you guys feel about numbers and things as we're coming out of COVID and how are things tracking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot